QXM
- 产品代码
- QXM
- 器械名称
- Implanted Tibial Electrical Urinary Continence Device
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 876.5305
- FDA 专业组
- Gastroenterology, Urology
- 上市路径
- 需提交 510(k) 上市前通告
- 标记
- 属植入器械
- 该代码近三年的 510(k)
- 3 件
- 其中 Summary 已存档
- 3 份,可直接下载
- FDA 历史累计 510(k)
- 4 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
An implanted tibial electrical urinary continence device is an implanted prescription device that receives power from a non-implanted external power source to provide electrical stimulation of the tibial nerve in proximity to the ankle. The device is intended for the treatment of overactive bladder related symptoms of urge urinary incontinence, urinary urgency, urinary frequency and nocturia.
该代码近三年的 510(k)(3 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K253651 | 2026-07-28 | Bluewind Medical , Ltd. | Revi System | |
| K252391 | 2025-12-12 | Bluewind Medical , Ltd. | Revi System | |
| K240037 | 2024-05-02 | Bluewind Medical , Ltd. | Revi System |
FDA 官方分类页: QXM
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。